Ladenburg Thalmann Financial Services’s Anavex Life Sciences AVXL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$7K	Buy	2,550 +800	+46%	+$2.1K	﹤0.01%	4625
2019 Q3	$6K	Hold	1,750	–	–	﹤0.01%	4591
2019 Q2	$7K	Sell	1,750 -500	-22%	-$1.55K	﹤0.01%	4570
2019 Q1	$7K	Sell	2,250 -1,575	-41%	-$3.76K	﹤0.01%	4511
2018 Q4	$6K	Sell	3,825 -300	-7%	-$681	﹤0.01%	4495
2018 Q3	$11K	Sell	4,125 -900	-18%	-$2.54K	﹤0.01%	4218
2018 Q2	$14K	Hold	5,025	–	–	﹤0.01%	4035
2018 Q1	$14K	Hold	5,025	–	–	﹤0.01%	4035
2017 Q4	$17K	Buy	5,025 +200	+4%	+$787	﹤0.01%	3881
2017 Q3	$20K	Buy	4,825 +800	+20%	+$3.56K	﹤0.01%	3671
2017 Q2	$21K	Hold	4,025	–	–	﹤0.01%	3574
2017 Q1	$23K	Buy	4,025 +200	+5%	+$1.03K	﹤0.01%	3456
2016 Q4	$15K	Hold	3,825	–	–	﹤0.01%	3648
2016 Q3	$14K	Hold	3,825	–	–	﹤0.01%	3606
2016 Q2	$24K	Hold	3,825	–	–	﹤0.01%	3218
2016 Q1	$19K	Buy	3,825 +1,000	+35%	+$4.4K	﹤0.01%	3277
2015 Q4	$16K	Buy	+2,825	New	+$20.1K	﹤0.01%	3366

Other funds holding AVXL

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AVXL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Anavex Life Sciences (AVXL) stake by 46% in Q4 2019, buying an estimated $2.1K and bringing the position to 2,550 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #4625.

Ladenburg Thalmann Financial Services first reported a position in AVXL in Q4 2015 and has held it in 17 quarters since. The position peaked at $24K in Q2 2016. 67 funds tracked by Wall St. Rank hold AVXL as of Q4 2019.

Ladenburg Thalmann Financial Services held 2,550 shares of Anavex Life Sciences worth $7K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 800 Anavex Life Sciences shares in Q4 2019, an estimated $2.1K.
Anavex Life Sciences made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4625 holding.
Ladenburg Thalmann Financial Services first reported a position in Anavex Life Sciences in Q4 2015 and has held it in 17 quarters since.
Ladenburg Thalmann Financial Services's Anavex Life Sciences position peaked at $24K in Q2 2016.
67 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.